The 2024 Career Development Award from LUNGevity supports early-career researchers in lung cancer in the USA. Funded researchers are expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy. Applicants must hold a doctoral degree and be within the first 5 years of their first faculty appointment with any academic institution, including research institutions that are not formally associated with a university, and have completed a postdoctoral training fellowship. Applicants must be based in the USA. The award provides up to 300,000 USD over 3 years (including indirect costs).
Letters of intent are due on February 9, 2024 and full invited applications are due on May 8, 2024.
May 8, 2024